Increased complements and high-sensitivity C-reactive protein predict heart failure in acute myocardial infarction.

about

Increased complements and high-sensitivity C-reactive protein predict heart failure in acute myocardial infarction.

Item

http://www.wikidata.org/entity/Q41416624

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Increased complements and high ...... n acute myocardial infarction.

@en

type

Item

label

Increased complements and high ...... n acute myocardial infarction.

@en

prefLabel

Increased complements and high ...... n acute myocardial infarction.

@en

P1476

Increased complements and high ...... n acute myocardial infarction.

@en

P2093

Anan Huang

http://www.w3.org/2001/XMLSchema#string

Danni Liu

http://www.w3.org/2001/XMLSchema#string

Keqiang Liu

http://www.w3.org/2001/XMLSchema#string

Liping Wei

http://www.w3.org/2001/XMLSchema#string

Qi Li

http://www.w3.org/2001/XMLSchema#string

Wenjun Jia

http://www.w3.org/2001/XMLSchema#string

Xin Qi

http://www.w3.org/2001/XMLSchema#string

Zongjin Li

http://www.w3.org/2001/XMLSchema#string

P2860

Structures of complement component C3 provide insights into the function and evolution of immunity

Use of multiple biomarkers to improve the prediction of death from cardiovascular causes

Molecular imaging of inflammation in atherosclerosis.

Imaging survival and function of transplanted cardiac resident stem cells

High-sensitivity C-reactive protein as a predictor of cardiovascular events after ST-elevation myocardial infarction.

Genetically elevated C-reactive protein and ischemic vascular disease.

Complement component 3 is necessary to preserve myocardium and myocardial function in chronic myocardial infarction.

The inflammatory response in myocardial injury, repair, and remodelling.

Complement activation and prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.

Elevated serum complement factors 3 and 4 are strong inflammatory markers of the metabolic syndrome development: a longitudinal cohort study.

P304

761-765

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/BR.2016.793

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28105343

http://www.w3.org/2001/XMLSchema#string

P932

5228438

http://www.w3.org/2001/XMLSchema#string